Replies to post #36243 on Relief Therapeutics Holding AG (RLFTF)

[Toohie]

So far trial results are phenomenal, unbelievable reduction in ICU and total hospital length of stay. Sure the dilution has hurt shareholders paper value, but this should get approval. And despite what many think I believe there is a good chance this drug will also work in many other patients who are suffering from respiratory decompensation. This is safe, natural, with low toxicity, and appears to be highly effective. Cannot wait till we get complete trial results